Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection-Reference-Cited by-同舟云学术

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

Published:2013-03-04 Issue:4 Volume:57 Page:1458-1468
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sun Yun-Fan,Xu Yang,Yang Xin-Rong,Guo Wei,Zhang Xin,Qiu Shuang-Jian,Shi Ruo-Yu,Hu Bo,Zhou Jian,Fan Jia

Funder

Major Program of National Natural Science Foundation of China

National Key Sci-Tech Project

National Natural Science Foundation of China

Research Fund for the Doctoral Program of Higher Education of China

Shanghai New Project for Excellent Youth

National Science Foundation for Distinguished Young Scholars of China

Shanghai Rising-Star Follow-up Program Fundings

Publisher

Wiley

Subject

Hepatology

Reference35 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Predictors and patterns of recurrence after resection of hepatocellular carcinoma;Cha;J Am Coll Surg,2003

3. Detection, clinical relevance and specific biological properties of disseminating tumour cells;Pantel;Nat Rev Cancer,2008

4. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients;Aktas;Breast Cancer Res,2009

5. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients;Raimondi;Breast Cancer Res Treat,2011

Cited by 339 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pt(IV) Prodrug Photoactivation: A Promising Strategy for Cancer Therapy;Current Protein & Peptide Science;2024-12

2. Investigating the Influence of Preoperative Trans Arterial Embolization (TAE) and Predictive Potential of Circulating Tumor Cells (CTCs) in Prognosis of Hepatocellular Carcinoma;Journal of Clinical and Experimental Hepatology;2024-11

3. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma;Molecular Cancer;2024-09-06

4. Changes of circulating tumor cells expressing CD90 and EpCAM in early-phase of atezolizumab and bevacizumab for hepatocellular carcinoma;Heliyon;2024-07

5. Serial Changes of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab;Cancers;2024-06-29